Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.

We conclude that low-coverage whole-genome sequencing without prior knowledge of the tumour alterations could become a useful tool for cell-free tumour DNA analysis of total CNAs in plasma from patients with gastro-oesophageal cancer.